Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest high-throughput screening Stories

2013-03-13 08:30:48

JUPITER, Fla., March 13, 2013 /PRNewswire-USNewswire/ -- The Scripps Research Institute (TSRI) and the Takeda Pharmaceutical Company have announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseases. The new agreement extends an initial collaboration launched in 2010 between scientists on the Florida campus of TSRI and Envoy Therapeutics that led to several breakthroughs in identifying potential new compounds for neurological and...

2013-01-10 12:24:41

WESTBROOK, Maine, Jan. 10, 2013 /PRNewswire/ -- Artel is launching the first in a new line of 100% DMSO-based Sample Solutions for use with the MVS® Multichannel Verification System. These will provide users with the ability to measure the accuracy and precision of volumes of DMSO dispensed into microwell plates. The first in the new line of DMSO solutions dramatically simplifies the volume verification process for users of sub-microliter liquid handling instruments, and will help them...

2012-10-15 07:22:10

CLEVELAND, Oct. 15, 2012 /PRNewswire/ -- ChanTest, the industry leading ion channel Contract Research Organization (CRO) announces today the addition of a 50,000 compound chemical library from Enamine Ltd., a leading provider of screening compounds and chemical building blocks. This compound library (3D Diversity Set) will be available to ChanTest clients effective immediately as a key tool for drug discovery services. (Logo: http://photos.prnewswire.com/prnh/20120817/CL58977LOGO )...

2012-09-19 22:22:09

COLOGNE, Germany, and SINGAPORE, September 20, 2012 /PRNewswire/ -- 2.6 million Euro financing will accelerate development of cutting-edge technology for protein analysis AyoxxA Biosystems, an international biotechnology company, today announces it has closed a 2.6 million Euro Series A financing round. The round was led by Wellington Partners Venture Capital and included NRW.BANK, HTGF - High-Tech-Gruenderfonds, and private investors, Rainer Christine and Dr. Gregor...

2012-05-24 02:28:41

GOTHENBURG, Sweden, May 24, 2012 /PRNewswire/ -- Cellectricon is pleased to announce the new Cellaxess Elektra Discovery Platform which represents a revolutionary development in automated electric field manipulation of adherent cells. Developed in close collaboration with leading pharmaceutical and biotechnology companies, the platform is highly diverse and can be applied to a wide variety of cellular manipulations in cell biology research. The platform enables in-situ...

2012-05-02 02:27:58

BIRMINGHAM, Ala., May 2, 2012 /PRNewswire-USNewswire/ -- Southern Research today announced that it will collaborate with the University of Texas Medical Branch at Galveston to develop and validate a high-volume, high-throughput screening platform in their Galveston National Laboratory (GNL). High-throughput screening (HTS) involves the process of rapidly screening and testing large numbers of different chemical compounds against select disease targets. This collaboration will provide the...

2012-01-25 12:00:00

MENLO PARK, Calif., Jan. 25, 2012 /PRNewswire/ -- Rathnam Chaguturu, Ph.D., has joined SRI International's Center for Advanced Drug Research (CADRE) as senior director of Exploratory Research. He will be based at SRI Shenandoah Valley in Harrisonburg, Virginia. In this role, Dr. Chaguturu will partner with SRI's drug discovery and development teams and expand collaborative research relationships with academia, disease foundations, nonprofits, and government agencies. "I am pleased to...

2011-11-21 10:05:45

Inspired by natural products, scientists on the Florida campus of the Scripps Research Institute have created a new class of small molecules with the potential to serve as a rich foundation for drug discovery. Combining the power of synthetic chemistry with some advanced screening technologies, the new approach could eventually expand by millions the number of provocative synthetic compounds available to explore as potential drug candidates. This approach overcomes substantial molecular...

2011-11-01 15:34:23

New research in the FASEB Journal suggests that new, calcium-activated chloride channels are promising and viable drug targets A new discovery by Californian scientists may lead to a pharmaceutical breakthrough for a wide range of illnesses that involve the hydration of cells that line the inner surfaces of our body's organs and tissues. In a new report appearing in the FASEB Journal (http://www.fasebj.org), the researchers describe how they used high-throughput screening to identify...

2011-10-11 09:43:14

Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors. Glioblastoma is one of the deadliest malignancies, typically killing patients within 12 to 18 months. These brain cancers consist of two kinds of cells, a larger, heterogeneous population of tumor cells and a smaller...